Galecto, Inc.GLTOEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company today is incorporated in the U.S., and has its operating headquarters in Copenhagen, Denmark.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| OrbiMed Advisors LLC | 2.80% | 749.6K | ▼ -1.40pp | 2023-09-18 |
| OF ABOVE PERSONS | 2.40% | 29.5K | ▼ -3.40pp | 2024-11-07 |
| Erik Otto | 0.00% | 2.1K | ▼ -6.70pp | 2024-08-29 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-30 | Jennifer Jarrett | See Remarks | Grant | 500.0K | $0.00 | $0 |
| 2026-02-09 | Fairmount Funds Management LLC | Director | Option exercise | 5.81M | $0.00 | $0 |
| 2026-02-09 | Fairmount Funds Management LLC | Director | Option exercise | 2.90M | $0.00 | $0 |
| 2026-02-09 | Julianne Bruno | Director | Option exercise | 129.0K | $0.00 | $0 |
1–4 of 4